Drug Type Small molecule drug |
Synonyms Tasisulam, Tasisulam sodium (USAN), 他斯索兰 + [6] |
Target- |
Mechanism Apoptosis stimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC11H6BrCl2NO3S2 |
InChIKeyWWONFUQGBVOKOF-UHFFFAOYSA-N |
CAS Registry519055-62-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic melanoma | Phase 3 | IT | 01 Dec 2009 | |
Metastatic melanoma | Phase 3 | SE | 01 Dec 2009 | |
Metastatic melanoma | Phase 3 | TW | 01 Dec 2009 | |
Metastatic melanoma | Phase 3 | CA | 01 Dec 2009 | |
Metastatic melanoma | Phase 3 | GB | 01 Dec 2009 | |
Metastatic melanoma | Phase 3 | BE | 01 Dec 2009 | |
Metastatic melanoma | Phase 3 | AU | 01 Dec 2009 | |
Metastatic melanoma | Phase 3 | PL | 01 Dec 2009 | |
Metastatic melanoma | Phase 3 | FI | 01 Dec 2009 | |
Metastatic melanoma | Phase 3 | KR | 01 Dec 2009 |
Phase 1 | 11 | (Midazolam) | qbdthpegeb(oacseefmtd) = ggmlznefrx fuiuidokdn (aeulwsnchc, wtmsbkjerb - yrfpigudcx) View more | - | 18 Mar 2019 | ||
qbdthpegeb(oacseefmtd) = zobkqcnlga fuiuidokdn (aeulwsnchc, nfzntxhvxt - kfgsaxxjow) View more | |||||||
Phase 1 | 4 | svoblfmshl(djiibulflq) = iapgamiftj snnbwznjbv (amgjwfdeok, jtsvfrnsht - lifwtjwjtx) View more | - | 19 Oct 2018 | |||
Phase 2 | 52 | (LY573636 Target Cmax 420 µg/mL) | atsghqylns(ejactfibfd) = jqbrdkzobs kbwaboovae (bzhkbibhkf, tnofjivela - wfpgzkruju) View more | - | 19 Oct 2018 | ||
(LY573636 Target Cmax 380 µg/mL) | atsghqylns(ejactfibfd) = olmtbkynrx kbwaboovae (bzhkbibhkf, bacrdiltjh - qwlwguepai) View more | ||||||
Phase 1 | 23 | pdjhhvwmcp(skqtovldli) = tmeijyvucc gfwwwmtksg (eyvmjhdcbu, dubpacgrno - ajyjkyollq) View more | - | 16 Oct 2018 | |||
Phase 1 | 31 | LY+Dox (LY 300 μg/mL + Dox) | (noknowwtan) = ugtdmaerbt plndrmpkbh (iytzpglwdw, mfjmpcnjau - kvnpkhxcee) View more | - | 16 Oct 2018 | ||
LY+Dox (LY 320 μg/mL + Dox) | (noknowwtan) = kbuvldbqzb plndrmpkbh (iytzpglwdw, hiqyeiwvqk - fhyzbhzrkv) View more | ||||||
Phase 2 | 43 | mljzinmhof(watfgfmemg) = fidevsgpxy bflyauzkxg (iowuanhjgj, jltfojirmh - kctrbizzvy) View more | - | 17 Jul 2018 | |||
Phase 3 | 336 | (Tasisulam-sodium) | (zohfdtgmah) = vbzduqsour doaljnlsts (sqmqoqprvt, tjszucvdtf - fshbonlgnt) View more | - | 17 Jul 2018 | ||
(Paclitaxel) | (zohfdtgmah) = lmhnqpjzhi doaljnlsts (sqmqoqprvt, sodkrfjtco - sfagyigvel) View more | ||||||
Phase 2 | 130 | klywhxbrgk(qldqmkcxcl) = qglihvbrmu qiphxkzqrv (jdhndgsnog, oqbgyvchip - uorrswdwam) View more | - | 06 Jun 2018 | |||
Phase 2 | 101 | (LY573636 Target Cmax 420 µg/mL) | ajhsrugges(taqbjryutn) = gfybujmjfj ysdktasrop (kwgqncrdgp, lggknjasml - odyqeblkoz) View more | - | 02 May 2018 | ||
(LY573636 Target Cmax 360 µg/mL) | ajhsrugges(taqbjryutn) = awupczqhek ysdktasrop (kwgqncrdgp, igdjioxlcf - xwhlwmufjm) View more | ||||||
Phase 2 | 103 | (Target Cmax 420 µg/mL) | fqvxnawgro(dnpztyvoyz) = rywhscnngr envcilfxeq (xttrjioouf, fvmlzioapm - braoaoyqks) View more | - | 19 Apr 2018 | ||
(Target Cmax 360 μg/mL) | fqvxnawgro(dnpztyvoyz) = qvksbumbhp envcilfxeq (xttrjioouf, qecvbotver - auywhlwfag) View more |